Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 3
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

349.8500 0.85 (0.24%)

NSE May 02, 2025 15:31 PM

44.91% Fall from 52W High

Volume: 261.4K

Aarti Drugs Ltd.

29 Oct 2021

349.85

0.24%

Result Update:Aarti Drugs

Hold: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

We believe this trend will continue for the upcoming quarters and therefore recommend HOLD rating 0n the stock with a Target Price of Rs 645/share.

Aarti Drugs Ltd. is trading below its 50 day SMA of 356.2